Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 6152 record(s)

Req # A-2024-000017

Adverse Drug Reaction (ADR) for ACITRETIN. Report number: 1071472. ADRs for ANASTROZOLE. Report numbers: 983160, 990116. ADR for CIPROFLOX. Report number: 1032025. ADR for Clonidine. Report number: 981372. ADRs for EPLERENONE. Reports number: 1026516, 1043922. ADRs for HYDROXYCHLOROQUINE. Report numbers: 1024918, 1026702, 1037377.

Organization: Health Canada

70 page(s)
April 2024

Req # A-2024-000028

Adverse Drug Reactions (ADRs) for Rosuvastatin-40. Report numbers: 000657015, 000702528. ADRs for Rosuvastatin-10. Report numbers: 000675846, 000928844. ADRs for Rosuvastatin-5. Report numbers: 000698101, 000705573. ADRs for Rosuvastatin-20. Report numbers: 000709470, 000720165.

Organization: Health Canada

29 page(s)
April 2024

Req # A-2024-000032

Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001049833, 001051635, 001052031, 001052040, 001052619, 001050859, 001053224, 001055320, 001065019, 001065607.

Organization: Health Canada

76 page(s)
April 2024

Req # A-2024-000068

Adverse Drug Reaction (ADR) for YESCARTA. Report number: 001076510.

Organization: Health Canada

3 page(s)
April 2024

Nothing to report this month

Organization: Canadian Museum of History

April 2024

Nothing to report this month

Organization: National Film Board

April 2024

Req # AF-2023-00081

Please provide all records, in all formats, including the processing and decisions, regarding the Application from the City of Belleville, Ontario, for funds from the Housing Accelerator Fund administered by CMHC from January 1, 2018 to the present (December 29, 2023).

Organization: Canada Mortgage and Housing Corporation

25 page(s)
March 2024

Req # AF-2023-00083

This is a request under this jurisdiction’s freedom of information legislation for records held by the Canadian Housing Mortgage Corporation. I am requesting the following: 1. Projects approved under the Rental Construction Financing Initiative as of June 30, 2021, including ones that are planned but have not received full funding: - The project's status, program, name, and location, - Proponent organization name and type (e.g. non-profit, private developer, etc.), - Financial commitment (total, loan, and grant / forgivable loan), - Number of total units for each project, - Number of “affordable” units, - Number of “accessible” units, - Average affordable rent charged by unit size, - Average rent for units not designated as affordable.

Organization: Canada Mortgage and Housing Corporation

30 page(s)
March 2024

Req # AF-2023-00084

This is a request under this jurisdiction’s freedom of information legislation for records held by the Canadian Housing and Mortgage Corporation. I am requesting: All projects approved under the Rental Construction Financing Initiative between July 1, 2021 and Dec 31, 2023, including ones that are planned but have not received full funding: - The project's status, program, name, and location, - Proponent organization name and type (e.g. non-profit, private developer, etc.), - Financial commitment (total, loan, and grant / forgivable loan), - Number of total units for each project, - Number of “affordable” units, - Number of “accessible” units, - Average affordable rent charged by unit size, - Average rent for units not designated as affordable. I would like to receive the information electronically.

Organization: Canada Mortgage and Housing Corporation

12 page(s)
March 2024

Req # AF-2023-00085

This is a request under this jurisdiction’s freedom of information legislation for records held by. I am requesting the following: Details on projects approved under the National Housing Co-Investment Fund as of June 30, 2021, including ones that are planned but have not received full funding: - The project's status, program, name, and location. - Proponent organization name and type (e.g. non-profit, private developer, etc.) - Financial commitment (total, loan, and grant / forgivable loan). - Number of total units for each project -Number of “affordable” units - Number of “accessible” units - Average affordable rent charged by unit size - Average rent for units not designated as affordable I would like to receive the information electronically.

Organization: Canada Mortgage and Housing Corporation

55 page(s)
March 2024
Date modified: